genes and tobacco use

18
GENES and TOBACCO USE

Upload: atara

Post on 17-Jan-2016

33 views

Category:

Documents


0 download

DESCRIPTION

GENES and TOBACCO USE. CAN GENES PREDICT WHO WILL…. develop heart disease? develop lung cancer? become a smoker? be able to quit?. FACTORS CONTRIBUTING to TOBACCO USE. Environment Tobacco advertising Conditioned stimuli Social interactions. Physiology Genetic predisposition - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: GENES and TOBACCO USE

GENES and TOBACCO USE

Page 2: GENES and TOBACCO USE

CAN GENES PREDICT WHO WILL…

develop heart disease?

develop lung cancer?

become a smoker?

be able to quit?

Page 3: GENES and TOBACCO USE

FACTORS CONTRIBUTING toTOBACCO USE

Physiology Genetic

predisposition Coexisting medical

conditions

Environment Tobacco

advertising Conditioned

stimuli Social interactions

Pharmacology Alleviation of

withdrawal symptoms

Weight control Pleasure

Tobacco Use

Page 4: GENES and TOBACCO USE

AVAILABLE EVIDENCE

Adoption studies

Twin studies

Twins reared apart studies

Linkage (family) studies

Page 5: GENES and TOBACCO USE

ADOPTION STUDIES

Adoption studies compare the similarities between

Children who have been adopted and their biological parents versus children who have been adopted and their adoptive parents

- OR -

Adoptive sibling pairs versus biological sibling pairs

Page 6: GENES and TOBACCO USE

ADOPTION STUDIES (cont’d)

Eysenck HJ, 1980.

Relationship Correlation Coefficient

Parent and offspring + 0.21

Identical (monozygotic) twins + 0.52

Fraternal (dizygotic) twins + 0.30

Siblings + 0.11

Adoptive parents and adoptive offspring

– 0.02

Adoptive siblings + 0.05

Correlations between relatives for average

reported cigarette consumption

Biological

Nonbiological

Page 7: GENES and TOBACCO USE

TWIN STUDIES

Twin studies compare the similarities between

Identical (monozygotic) twins and fraternal (dizygotic) twins

Concordant or discordant?Higher concordance of tobacco usefor identical than for fraternal twins

Estimated heritability for smoking = 0.53

Page 8: GENES and TOBACCO USE

TWINS REARED APART STUDIES

Combine aspects of adoption and twin studies

Separate the effects of genetics from the effects of environment

Have found that 60% of the variance in regular smoking in men and women born after 1940 is attributable to genetic factors (Kendler et al., 2000)

Page 9: GENES and TOBACCO USE

LINKAGE STUDIES

Use human genome mapping to enable researchers to identify genes associated with traits or disorders

Examine family pedigrees to determine modes of inheritance of disorders

Are more difficult when multiple genes have a role

Page 10: GENES and TOBACCO USE

LINKAGE STUDIES (cont’d)

Linkage studies of smoking

1. Identify families with affected individuals (i.e., tobacco users)

2. Genotype two or more affected siblings and biological parents

3. Conduct linkage analysis to determine whether affected siblings are likely to share the same gene as the parents

Page 11: GENES and TOBACCO USE

“CANDIDATE” GENES

Candidate genes are genes hypothesized to contribute to the susceptibility for a trait or disorder.

Two current lines of research in the area of candidate genes for smoking: Genes affecting nicotine pharmacodynamics Genes affecting nicotine pharmacokinetics

Page 12: GENES and TOBACCO USE

P h a r m a c o l o g y

Nicotine Metabolism• CYP2A6 enzyme• CYP2D6 enzyme

DOPAMINE Synthesis

• Tyrosine hydroxylase Receptor activation

• DRD1, DRD2, DRD3, DRD4, DRD5 Reuptake

• Dopamine transporter (SLC6A3) Metabolism

• Catechol-O -methyltransferase• MAO A, MAO B• Dopamine ß-hydroxylase

SEROTONIN Synthesis

• Tryptophan hydroxylase (TPH) Reuptake

• Serotonin transporter (5-HTT)

Pharmacodynamics Pharmacokinetics

Page 13: GENES and TOBACCO USE

Genetic Effects on the Dopamine Reward Pathway

Page 14: GENES and TOBACCO USE

GENETIC EFFECTS on NICOTINE METABOLISM

Nicotine

~80%

Cotinine

Reprinted with permission, Benowitz et al. (1994).

NorcotinineCotinine-N-oxide

Cotinineglucuronide

Nicotineglucuronide

Trans-3'-hydroxycotinine

glucuronide

Nicotine Nicotine-1'-N-oxide Nornicotine

Trans-3'-hydroxycotinine

CotinineTrans-3'-

hydroxycotinine

4.2%

9.8%4.4%

0.4%

13.0%

12.6%

2.4%

2.0%

7.4%

33.6%

Page 15: GENES and TOBACCO USE

Nicotine

Cotinine

1) CYP2A6

2) Aldehyde oxidase

GENETIC EFFECTS on NICOTINE METABOLISM (cont’d)

Page 16: GENES and TOBACCO USE

GENES AND TOBACCO USE:SOCIETAL AND POLICY IMPLICATIONS

If genetic tests become available, should society encourage genetic testing for tobacco dependence?

Single gene or multiple gene?

Prevalence of the gene(s) in the population?

Is there an effective intervention to prevent smoking in those who are susceptible?

Impact of positive tests, and negative tests?

Page 17: GENES and TOBACCO USE

GENES AND TOBACCO USE:SOCIETAL AND POLICY IMPLICATIONS (cont’d)

Improved treatment for tobacco dependence?

Perhaps the most promising benefit of genetic research on smoking

Improved understanding of tobacco dependence might result in development of more effective medications

Pharmacotherapy treatment matching

Page 18: GENES and TOBACCO USE

GENES and TOBACCO USE: SUMMARY

Research in the area of genetics and smoking is in its infancy; however, there appears to be a genetic component to tobacco use.

Tobacco use is a complex behavior, with many determinants.

More research is needed.

Genetic research and testing must proceed with caution because the societal stakes are high.